Oxford Asset Management’s Intersect ENT, Inc XENT Stock Holding History

Oxford Asset Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-42,300	Closed	-$963K	–	2033
2019 Q2	$963K	Sell	42,300 -45,640	-52%	-$1.23M	0.02%	996
2019 Q1	$2.83M	Sell	87,940 -26,227	-23%	-$812K	0.06%	420
2018 Q4	$3.22M	Buy	+114,167	New	+$3.34M	0.08%	273
2018 Q3	–	Sell	-65,206	Closed	-$2.45M	–	2015
2018 Q2	$2.45M	Buy	65,206 +20,667	+46%	+$811K	0.05%	541
2018 Q1	$1.75M	Sell	44,539 -73,989	-62%	-$2.7M	0.04%	648
2017 Q4	$3.86M	Buy	118,528 +40,161	+51%	+$1.2M	0.08%	298
2017 Q3	$2.37M	Buy	+78,367	New	+$2.32M	0.05%	538

Other funds holding XENT

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Oxford Asset Management's XENT Position: Q3 2019 in Review

Oxford Asset Management sold out of Intersect ENT, Inc (XENT) in Q3 2019, closing a stake of 42,300 shares — an estimated $963K sold.

Oxford Asset Management first reported a position in XENT in Q3 2017 and held it in 7 quarters. The position peaked at $3.86M in Q4 2017. 112 funds tracked by Wall St. Rank hold XENT as of Q3 2019.

Oxford Asset Management reported no remaining Intersect ENT, Inc position as of Q3 2019 after selling out during the quarter.
Oxford Asset Management sold 42,300 Intersect ENT, Inc shares in Q3 2019, an estimated $963K.
Oxford Asset Management first reported a position in Intersect ENT, Inc in Q3 2017 and held it in 7 quarters.
Oxford Asset Management's Intersect ENT, Inc position peaked at $3.86M in Q4 2017.
112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2019.

Based on Oxford Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.